The PCV13 vaccine makes it easier for the immune system to attack S. pneumoniae and produce antibodies by linking the ...

The levels of antibodies that correlate with protection against pneumococcal ... either meningococcal polysaccharide serogroup A or placebo. The 6- and 12-valent vaccines achieved a protective ...

In addition to increasing vaccine coverage in older adults, they need to monitor the changing epidemiology of pneumococcal serotypes causing invasive disease. [134] In the face of these changes ...

Babies treated with antibiotics in the first few weeks of their life are likely to show weaker immune responses to essential ...

polysaccharide-based jab Pneumovax 23. Sanofi's new challenger is billed as a "next-generation" pneumococcal conjugate vaccine that, according to the company, is the first candidate with more than ...

Pneumococcal 20-valent conjugate ... receiving 13-valent pneumococcal conjugate vaccine (Prevnar 13) followed 1 month later with 23-valent polysaccharide vaccine (PPSV23). The immune responses ...

Already facing one rival to its blockbuster pneumococcal ... combines polysaccharide and protein antigens – joined with a biotin-rhizavidin bond – that can stimulate both B cell (antibody ...

Unlike the Conjugate pneumococcal vaccine (PCV), the PPSV vaccine is made with the Polysaccharide (sugars ... the immune ...

Prevenar 13 is a mixture of the outer sugar coating (polysaccharide ... child have ever had an allergic reaction to pneumococcal or diphtheria vaccines, or any of the ingredients listed at ...

NA: Not applicable; PCV-7: 7-valent pneumococcal conjugate vaccine; PCV-13: 13-valent pneumococcal conjugate vaccine; PPV23: 23-valent pneumococcal polysaccharide vaccine.